| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-13 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |